| Janssen-Cilag AG - REKAMBYS 900 mg / 3 ml, Depot-Injektionssuspension |
| 67742 | | 02 | | REKAMBYS 900 mg / 3 ml | | Depot-Injektionssuspension | | J05AG05 | | Rilpivirine | | 08.10.2021 | | |
|
| Composition |
| rilpivirinum 900 mg, poloxamerum 338, glucosum monohydricum, natrii dihydrogenophosphas monohydricus, acidum citricum monohydricum, natrii hydroxidum, aqua ad iniectabile q.s. ad suspensionem pro 3 ml corresp. natrium 2.49 mg. |
| Packungsbestandteile |
| Depot-Injektionssuspension | | | | | | | | Active Agent | Dose |
|---|
| Rilpivirinum | 900mg / 3ml |
| | BAG: Active Agent | Dose |
|---|
| Rilpivirinum | 900 mg |
| | | | Inactive agents | Dose |
|---|
| Citric Acid Monohydrate | | | Glucose Monohydrate | | | Sodium Dihydrogenophosphate Monohydrate | | | Sodium Hydroxide | | | Poloxamer | 338 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | | 551.43 | 616.15 | A | SL | Yes |
|
